BioHybrid Solutions LLC (BHS) is a Carnegie Mellon University spin-off, focused on next-generation protein-polymer biotherapeutics as alternatives to PEGylation.  A fast-growing company with a network of committed partners and collaborators working to deliver the next generation of biotherapeutics.

Biotechnology

BioHybrid Solutions

Brook Bankes-Polk

Anthony Manning

Krzysztof Matyjaszewski

Antonina Simakova

The Science and Research team at BioHybrid Solutions LLC focuses on the development, analysis, and optimization of next-generation protein-polymer biotherapeutics. This team conducts cutting-edge research, performs rigorous analytical testing, and collaborates closely with partners to innovate alternative solutions to PEGylation, driving the company's biotherapeutic advancements.

Science and Research

About

Team members

Other teams at BioHybrid Solutions

Administrative and Management Team

Leadership Team